Joe Verghese MD
Dementia & Geriatrics
Professor and Chair, Department of Neurology Renaissance School of Medicine, Stony Brook, NY
Join to View Full Profile
Neurology Associates of Stony Brook4 Smith Haven Mall Suite 105Lake Grove, NY 11755
Phone+1 631-444-2599
Fax+1 631-392-7213
Dr. Verghese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joe Verghese is a neurologist based in Lake Grove, NY, with subspecialties in dementia and geriatrics. He completed his medical education at St. John's Medical College, followed by a neurology residency and clinical neurophysiology fellowship at Montefiore Medical Center/Albert Einstein College of Medicine. Dr. Verghese was a professor at Montefiore Medical Center - Einstein Campus from 2000 to 2024. He is currently professor and Chair of Neurology at the Renaissance School of Medicine, Stony Brook University - since 2024. He has published over 300 research papers and reviews in notable journals. He serves as the principal investigator for multiple NIH studies including the clinical trial "5-Cog 2.0: A Pragmatic Clinical Trial."
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Clinical Neurophysiology, 1998 - 1999
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1995 - 1998
- St. John's Medical CollegeClass of 1989
Certifications & Licensure
- NY State Medical License 2004 - 2027
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- 5-Cog 2.0: A Pragmatic Clinical Trial Start of enrollment: 2023 Aug 18
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Gray Matter Covariance Networks Associated with Parental Longevity - Results from the LonGenity Study.Natalie Delpratt, Nir Barzilai, Sofiya Milman, Sandra Aleksic, Erica Weiss
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2025-04-28 - Improving Early Dementia Detection Among Diverse Older Adults With Cognitive Concerns With the 5-Cog Paradigm: Protocol for a Hybrid Effectiveness-Implementation Clini...Rachel Beth Rosansky Chalmer, Emmeline Ayers, Erica F Weiss, Nicole R Fowler, Andrew Telzak
JMIR Research Protocols. 2025-04-03 - Two Decades of the Walking While Talking Test: A Narrative Review.Kelly Cotton, Joe Verghese
Journal of the American Medical Directors Association. 2025-03-01
Press Mentions
- Slower Walking in Older Adults Could Signal Early Dementia, Study FindsDecember 6th, 2024
- Walking on Curved Path Can Give Clues to Cognitive Decline, Researchers FindMarch 30th, 2024
- Quick Test Helps Detect DementiaJune 8th, 2024
Grant Support
- Gait as a Preclinical Marker for Alzheimer’s Disease and Dementia: insights from super-movers, usual-movers, and slow-moversALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- Gait as a Preclinical Marker for Alzheimer’s Disease and Dementia: insights from super-movers, usual-movers, and slow-moversALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- Gait as a Preclinical Marker for Alzheimer’s Disease and Dementia: insights from super-movers, usual-movers, and slow-moversALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- Cognitive decline and dementia in older Kerala AmericansALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- Gait as a Preclinical Marker for Alzheimer’s Disease and Dementia: insights from super-movers, usual-movers, and slow-moversALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
- Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
- Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
- Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
- 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
- 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
- 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
- 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
- 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
- Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
- Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
- The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center studyALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
- Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
- Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
- Kerala-Einstein Aging StudyALBERT EINSTEIN COLLEGE OF MEDICINE2011–2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
